Listen to the article
Medical experts gathered Monday night in South Bend to address what they characterized as a growing wave of vaccine disinformation following recent controversial changes to federal health messaging.
The Medical Education Foundation of South Bend convened a panel of immunization specialists in direct response to significant alterations made last month to a Centers for Disease Control and Prevention webpage. The webpage, which previously stated definitively that “Vaccines Do Not Cause Autism,” was revised to suggest that health authorities had potentially ignored links between vaccines and autism—a change that directly contradicts decades of scientific research debunking such connections.
“I think that what we’re witnessing is a full-on assault on vaccine policy and vaccine confidence in this country,” said Richard Hughes, a health lawyer with Epstein Becker and Green, expressing a sentiment echoed by many attendees. “The secretary really has undermined a lot of our public health institutions and really is taking actions that undermine evidence-based vaccine policy, and it’s very confusing for patients, for providers, and I think it’s really going to be detrimental for public health.”
The panel discussion focused heavily on Health Secretary Robert F. Kennedy Jr.’s vaccine policies, which have alarmed many public health officials. Kennedy, who has long expressed skepticism about vaccine safety despite scientific consensus, has implemented several policy changes since his appointment that many medical professionals view as dangerous backsliding in public health protection.
Lisa Robertson, executive director of the Indiana Immunization Coalition, warned about immediate policy implications facing Indiana residents. She noted that the CDC’s vaccine advisory committee will meet later this week to vote on potential changes to the childhood schedule for Hepatitis B vaccines.
“If ACIP comes out and says that Hepatitis B is not recommended or we aren’t going to administer it until the child is 12, that means that kindergarten immunization requirement we have for Hepatitis B would no longer be lawful because in Indiana, our law is based on the ACIP recommendation,” Robertson explained. “Really then we’ll put those children at risk for Hepatitis B infection.”
The potential policy shift represents one of several concerning changes that could roll back decades of progress in preventing childhood diseases, according to the panel. Public health officials in Indiana are particularly alarmed given that the state has already experienced a 14 percent decrease in infant vaccination rates between 2020 and 2023.
Panel members emphasized the critical importance of community-wide vaccination in protecting vulnerable populations, especially those too young to be immunized. The discussion took on a deeply personal tone when Katie Van Tornhout shared the heartbreaking story of her daughter Callie, who died at just 37 days old after contracting whooping cough from an unvaccinated healthcare worker in a neonatal intensive care unit.
“There’s a lot of naysayers; there’s a lot of people that don’t have the right information,” said Van Tornhout, who has since become a vaccine advocate. “If you take that away from us, with recommendations and stuff, we’re all going to see it, and it’s going to affect every one of us in some way. Nobody deserves to lose their child or their life to a disease that’s preventable.”
The CDC webpage change represents what many health professionals see as part of a broader pattern of undermining scientific consensus on vaccine safety, potentially reversing decades of progress in public health. While the official justification for the webpage revision has not been fully explained, it aligns with views long held by Kennedy, who has previously suggested connections between vaccines and autism despite overwhelming scientific evidence to the contrary.
Despite these concerns, panelists noted some encouraging trends. Infant vaccination rates in Indiana have begun to rebound over the past two years, offering some hope that public confidence in immunizations might be recovering. Health officials emphasized that continuing public education about vaccine safety and effectiveness remains crucial to maintaining these positive trends and preventing outbreaks of preventable diseases.
As federal health policy continues to evolve under the current administration, medical professionals in Indiana and nationwide remain vigilant about potential threats to established immunization protocols and public health protections.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


23 Comments
Interesting update on Medical Experts Address Vaccine Misinformation at South Bend Panel. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Medical Experts Address Vaccine Misinformation at South Bend Panel. Curious how the grades will trend next quarter.
The cost guidance is better than expected. If they deliver, the stock could rerate.
The cost guidance is better than expected. If they deliver, the stock could rerate.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.